Novartis AG

BMV:NVSN

Novartis AG is a global drugmaker that discovers, develops, manufactures, and sells prescription medicines. Its main products are branded treatments for serious illnesses, including cancer, immune diseases, heart and kidney conditions, eye disease, and some rare disorders. It does not sell everyday consumer health products; its business is centered on medicines that doctors prescribe to patients. The company makes money mainly by selling these medicines to hospitals, clinics, pharmacies, and health systems, which then dispense them to patients. In some markets it also earns from licensing and related pharmaceutical agreements. Novartis spends heavily on research and clinical development because its products must be proven safe and effective before they can reach the market. What makes Novartis different is its role near the top of the drug value chain. It is not just a manufacturer; it is a research-driven company that creates patented medicines and then handles the path from lab discovery to commercial sale. That gives it a business model built around specialized science, long product development cycles, and close ties to the medical system rather than mass-market retail.